Researchers Grow Breast Cancer Tissue from Transplanted Mammary Stem Cells
In the battle against breast cancer, medicine may be shooting at the wrong enemy. Much like using a weed-whacker to remove the top of lawn weeds, leaving the root behind, conventional treatments that...
View ArticleClik here to view.
Mushroom-Supplemented Soybean Extract Shows Therapeutic Promise for Advanced...
A natural, nontoxic product called genistein-combined polysaccharide, or GCP, which is commercially available in health stores, could help lengthen the life expectancy of certain prostate cancer...
View ArticleUC Davis Research Advances Efforts to Precent Dangerous Blood Clots
Study will help physicians calculate risk of post-surgical venous thromboembolisms. New research from the UC Davis Comprehensive Cancer Center may help clinicians determine which patients are at...
View ArticleClik here to view.
Fatty Acid Metabolite Shows Promise Against Cancer in Mice
A team of UC Davis scientists has found that a product resulting from a metabolized omega-3 fatty acid helps combat cancer by cutting off the supply of oxygen and nutrients that fuel tumor growth and...
View ArticleClik here to view.
Small Molecule Unlocks Key Prostate Cancer Survival Tactic
The most recent in a series of studies from a team at the UC Davis Comprehensive Cancer Center has shown that a single molecule is at the heart of one of the most basic survival tactics of prostate...
View ArticleClik here to view.
Health Care Worker Visits Increase Screening for Hepatitis B among Hmong...
Study is the first randomized trial to assess the efficacy of home-based health education for the Hmong.
View ArticleClik here to view.
UC Davis Radiation Oncology Chief Leads Development of New Prostate Cancer...
The guideline, released jointly by the American Society for Radiation Oncology (ASTRO) and the American Urological Association (AUA), for the first time provides evidence- and consensus-based...
View ArticleNearly Half of Sarcoma Surgeries Done by Nonsurgical Oncology Specialists
Orthopedic oncologists and surgical oncologists, who have been trained in the complex procedures required to remove sarcomas located deep in the muscles and other soft tissues of the limbs, conducted...
View ArticleClik here to view.
Targeting Aggressive Prostate Cancer
Researchers identify key mechanism behind aggressive prostate cancer that spurs tumor growth and metastasis and makes cancers resistant to treatment.
View ArticleStudy Applies Timely Cost-Effectiveness Analysis to State Breast Cancer...
When public health budgets are constrained, mammography screening should begin later and occur less frequently, a cost-effectiveness analysis for California's Every Woman Counts (EWC) program concludes.
View ArticleClik here to view.
Better Guidelines, Coordination Needed for Prostate Cancer Specialists
With a deluge of promising new drug treatments for advanced prostate cancer on the market, a new model of care is needed that emphasizes collaboration between urologists and medical oncologists,...
View ArticleClik here to view.
Detecting Gastric Cancer Cancer Early - It's in the Sugars
An international team of researchers led by UC Davis in collaboration with scientists in Mexico and South Korea have taken a first step towards identifying glycans -- sugars attached to proteins --...
View ArticleClik here to view.
Bone Turnover Markers Predict Prostate Cancer Outcomes
Biomarkers for bone formation and resorption predict outcomes for men with castration-resistant prostate cancer, a team of researchers from UC Davis and their collaborators have found. Their study,...
View ArticleClik here to view.
UC Davis Researchers One Step Closer to Ovarian Cancer Marker
The hunt is on to find biomarkers that detect cancer, but it's a challenging process. Early successes often are followed by heartbreaking failures. But now, researchers at UC Davis have verified that...
View ArticleClik here to view.
Joint Cancer Center Study Finds Barriers to Minority Clinical Trial...
A new study involving researchers from UC Davis and four other National Cancer Institute-designated cancer centers reveals important barriers that limit minority group participation in cancer clinical...
View ArticleClik here to view.
Minority Clinical Trials Participation and Analysis Still Lag 20 Years After...
Twenty years after Congress mandated that research funded by the National Institutes of Health include minorities, less than 5 percent of trials participants are non-white, and less than 2 percent of...
View ArticleClik here to view.
UC Davis Faculty Drive Efforts to Improve CT Safety
UC Davis clinicians and physicists have recommended new strategies to make computed tomography (CT) safer, including adoption of a new metric for dose measurement, ways to manage exposure protocols...
View ArticleClik here to view.
Potential Lung Cancer Vaccine Shows Renewed Promise
Researchers at UC Davis have found that the investigational cancer vaccine tecemotide, when administered with the chemotherapeutic cisplatin, boosted the immune response and reduced the number of...
View Article